Transforming collaborations between ras and nuclear oncogenes - PubMed

Affiliations

• PMID: 2223387

Review

Transforming collaborations between ras and nuclear oncogenes

H E Ruley. Cancer Cells. 1990 Aug-Sep.

Abstract

Nuclear proteins encoded by both cellular oncogenes and DNA tumor viruses enable activated ras oncogenes to transform a variety of cell types to a tumorigenic state. The interactions are complementary, suggesting that collaborating oncogenes release cells from controls that preclude transformation by ras alone. The nuclear oncoproteins bind both protein and nucleic acid targets and affect processes important in transcription and cell cycle control. Transforming collaborations between oncogenes provide a genetic context to study biochemical interactions involved in normal growth control and to identify mechanisms important in multistep carcinogenesis.

Similar articles

• Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.

  Spandidos DA. Spandidos DA. Anticancer Res. 1985 Sep-Oct;5(5):485-98. Anticancer Res. 1985. PMID: 3904595

• Cooperation of oncogenes in the multistep transformation of established fibroblasts in culture.

  Davenport EA, Drobes BL, Menke SL, Vaidya TB, Taparowsky EJ. Davenport EA, et al. Anticancer Res. 1988 Sep-Oct;8(5A):959-69. Anticancer Res. 1988. PMID: 2845855

• Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.

  Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, Allday MJ. Parker GA, et al. Oncogene. 1996 Dec 19;13(12):2541-9. Oncogene. 1996. PMID: 9000128

• [Retroviral oncogenes and their cellular proto-oncogenes].

  Zabarovskiĭ ER. Zabarovskiĭ ER. Mol Biol (Mosk). 1985 Jan-Feb;19(1):9-35. Mol Biol (Mosk). 1985. PMID: 3885006 Review. Russian.

• Non-nuclear oncogenes and the regulation of gene expression in transformed cells.

  Bortner DM, Langer SJ, Ostrowski MC. Bortner DM, et al. Crit Rev Oncog. 1993;4(2):137-60. Crit Rev Oncog. 1993. PMID: 8380545 Review.

Cited by

• Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.

  Rieske P, Bartkowiak J, Szadowska A, Debiec-Rychter M. Rieske P, et al. Mol Pathol. 1999 Apr;52(2):64-7. doi: 10.1136/mp.52.2.64. Mol Pathol. 1999. PMID: 10474683 Free PMC article.

• Oncogenic regulation and function of keratins 8 and 18.

  Oshima RG, Baribault H, Caulín C. Oshima RG, et al. Cancer Metastasis Rev. 1996 Dec;15(4):445-71. doi: 10.1007/BF00054012. Cancer Metastasis Rev. 1996. PMID: 9034603 Review.

• Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

  Sheng-Fowler L, Cai F, Fu H, Zhu Y, Orrison B, Foseh G, Blair DG, Hughes SH, Coffin JM, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Int J Biol Sci. 2010 Mar 29;6(2):151-62. doi: 10.7150/ijbs.6.151. Int J Biol Sci. 2010. PMID: 20376206 Free PMC article.

• Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

  Lowe SW, Jacks T, Housman DE, Ruley HE. Lowe SW, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30. doi: 10.1073/pnas.91.6.2026. Proc Natl Acad Sci U S A. 1994. PMID: 8134344 Free PMC article.

• Mitogenic pathways regulated by G protein oncogenes.

  Gupta SK, Gallego C, Johnson GL. Gupta SK, et al. Mol Biol Cell. 1992 Jan;3(1):123-8. doi: 10.1091/mbc.3.1.123. Mol Biol Cell. 1992. PMID: 1550954 Free PMC article. Review. No abstract available.

Publication types

MeSH terms

Substances